NIH-funded research NIH-funded research

Developing models to understand infectious diseases.

Official title: Pre-Clinical Models of Infectious Diseases

Funded at University of Louisville · NIH-11197683 · Data updated 2026-11-12

This study is working on building models that mimic infectious diseases to help researchers find better treatments, which could lead to new options for patients like you in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startJuly 15, 2024
Project endJuly 14, 2031
Funding year2024
Award (this year)$2,500
NIH project number75N93024D00036-0-759302400001-1
Project IDNIH-11197683 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit include individuals at risk of infectious diseases or those involved in clinical trials for new treatments.

Less likely to help

Patients with non-infectious diseases or those not at risk for infectious diseases may not receive any benefit from this research.

What this research studies

This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of medical countermeasures before they are tested in humans. Patients may benefit from advancements in treatment options that arise from the insights gained through these models. The research employs a systematic approach to model development, ensuring that findings are relevant to real-world scenarios.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases.

How similar studies have gone: Other research has shown success in using pre-clinical models to develop effective treatments for infectious diseases, indicating that this approach is both tested and promising.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.